Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

Study ID
NCT02246634

Study type
Interventional

Study phase
Not Applicable

Study status
Recruiting

Trial Acronym

SERENADE

Trial Summary

Eligible patients with high risk colorectal malignancy (T3/4, spread greater than 5mm, EMVI positive) will have additional surveillance of breath hold T1, T2 and DW-MRIs (no IV contrast) post surgery six monthly for three years. Findings of liver MRIs as reported by radiology PI will be shared with their local MDT who make decisions as appropriate, including the management of any identified liver metastases, according to local protocol.

More informations

Trial Starting Date

Aug 31,2014

Requirements

Gender All
Minimum age 16 Years
Maximum age N/A

Enrollement Limit

282